Skip to main content
Icon of paper report Annual Reports & Proxies Icon of email envelope Email page Icon of envelope with exclamation mark Email Alert Icon of RSS logo RSS News Feeds Icon of printer Print view
Button to close investor relations menu

    Welcome

    United Therapeutics is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.

    Explore our robust pipeline
    Download our corporate presentation
    View our responsibility and public benefit report
    Sign up for email alerts
    Contact UTHR
    News
    Financials & Filings

    Most Recent Financial Report

    Stock Information
    Learn More
    Events & Presentations
    Learn More
    Corporate Governance
    Learn More
    Contact UTHR

    United Therapeutics
    Telephone: 301-608-9292
    Email: ir@unither.com



    To contact our Transfer Agent:

    Mailing address:
    Computershare
    P.O. Box 43006
    Providence, RI 02940-3006

    Courier delivery:
    Computershare
    150 Royall St., Suite 101
    Canton, MA 02021

    Website:
    www.computershare.com/investor

    Tel: 1 (201) 680-6578
    Toll Free: (800) 524-4458

    Contact